Higher central circadian temperature amplitude is associated with greater metabolite rhythmicity in humans
- PMID: 39039133
- PMCID: PMC11263371
- DOI: 10.1038/s41598-024-67297-y
Higher central circadian temperature amplitude is associated with greater metabolite rhythmicity in humans
Abstract
Robust circadian rhythms are essential for optimal health. The central circadian clock controls temperature rhythms, which are known to organize the timing of peripheral circadian rhythms in rodents. In humans, however, it is unknown whether temperature rhythms relate to the organization of circadian rhythms throughout the body. We assessed core body temperature amplitude and the rhythmicity of 929 blood plasma metabolites across a 40-h constant routine protocol, controlling for behavioral and environmental factors that mask endogenous temperature rhythms, in 23 healthy individuals (mean [± SD] age = 25.4 ± 5.7 years, 5 women). Valid core body temperature data were available in 17/23 (mean [± SD] age = 25.6 ± 6.3 years, 1 woman). Individuals with higher core body temperature amplitude had a greater number of metabolites exhibiting circadian rhythms (R2 = 0.37, p = .009). Higher core body temperature amplitude was also associated with less variability in the free-fitted periods of metabolite rhythms within an individual (R2 = 0.47, p = .002). These findings indicate that a more robust central circadian clock is associated with greater organization of circadian metabolite rhythms in humans. Metabolite rhythms may therefore provide a window into the strength of the central circadian clock.
Keywords: Biological rhythms; Circadian clock; Circadian organization; Core body temperature; Peripheral oscillators.
© 2024. The Author(s).
Conflict of interest statement
SF served as a Project Leader, SMWR and SWL served as Program Leaders, and CA served as a Theme Leader in the Cooperative Research Centre (CRC) for Alertness, Safety, and Productivity, Melbourne, Australia. CA has received a research award/prize from Sanofi-Aventis; contract research support from VicRoads, Rio Tinto Coal Australia, National Transport Commission, Tontine/Pacific Brands and VicRoads; lecturing fees from Brown Medical School/Rhode Island Hospital, Ausmed, Healthmed and TEVA Pharmaceuticals; conference travel reimbursements from Philips Healthcare; and consulted with the Transport Accident Commission (TAC) and the National Transportation Committee (NTC) through her institution. SMWR has received research funding from Philips Lighting; Vanda Pharmaceuticals; ResMed Foundation; Respironics Sleep and Respiratory Research Foundation; Cephalon Inc.; and Takeda Pharmaceuticals North America. SWL has received consulting fees from the BHP Billiton, EyeJust Inc., Noble Insights, Rec Room, Six Senses, Stantec and Team C Racing; consults with Akili Interactive, Apex 2100 Ltd., Consumer Sleep Solutions, Headwaters Inc., Hintsa Performance AG, KBR Wyle Services, Light Cognitive, Lighting Science Group corporation/HealthE, Mental Workout/Timeshifter and View Inc.; has received honoraria and travel and/or accommodation expenses from Bloxhub, Emory University, Estée Lauder, Ineos, MIT, Roxbury Latin School, and University of Toronto, IES, Mental Workout, Solemma, and Wiley and royalties from Oxford University Press; holds equity in iSleep pty; has received an unrestricted equipment gift from F. Lux Software LLC, a fellowship gift from Stockgrand Ltd; holds an investigator-initiated grant from F. Lux Software LLC and a Clinical Research Support Agreement and Clinical Trial Agreement with Vanda Pharmaceuticals Inc; is an unpaid Board Member of the Midwest Lighting Institute (non-profit); holds a pending patent for a 'Method and system for generating and providing notifications for a circadian shift protocol' (US20190366032A1); and has served as a paid expert in legal proceedings related to light, sleep and health. AJKP and SWC have received research funding from Versalux and Delos, and are co-directors of Circadian Health Innovations Pty Ltd. SWC has consulted for Dyson and received research funding from Beacon Lighting. DPW, KJJ, LKG, BN, MM, and DT declare that they have no conflict of interest.
Figures

References
-
- Windred, D. P. et al. Personal light exposure patterns and incidence of type 2 diabetes: Aanalysis of 13 million hours of light sensor data and 670,000 person-years of prospective observation. Lancet Reg. Health Eur.10.1016/j.lanepe.2024.100943 (2024).
-
- Burns, A. C. et al. Day and night light exposure are associated with psychiatric disorders: An objective light study in> 85,000 people. Nat. Mental Health.11, 853–862 (2023).
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources